全球多重診斷市場

到 2030 年，全球多重診斷市場規模將達到 286 億美元

全球多重診斷市場預計 2024 年為 136 億美元，到 2030 年將達到 286 億美元，2024 年至 2030 年的複合年成長率為 13.2%。設備及配件是報告中分析的細分市場之一，預計複合年成長率為 11.0%，到分析期結束時將達到 154 億美元。在分析期內，套件和試劑部分的複合年成長率預計為 16.1%。

美國市場估計為37億美元；預計中國年複合成長率為 17.3%

預計 2024 年美國多重診斷市場價值將達到 37 億美元。作為世界第二大經濟體的中國，預計到 2030 年市場規模將達到 60 億美元，在 2024-2030 年分析期內的複合年成長率為 17.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 9.8% 和 11.6%。在歐洲，德國的複合年成長率預計為 10.4%。

全球多重診斷市場－主要趨勢與促進因素摘要

為什麼多重診斷在臨床和 POC 檢測中越來越受歡迎

多重診斷是指能夠從單一生物樣本同時檢測多種分析物（例如蛋白質、核酸和病原體）的分析平台。這種方法顯著提高了診斷效率，縮短了周轉時間，並節省了樣本量，使其在傳染病檢查、腫瘤學、自體免疫疾病篩檢和藥物基因組學領域中越來越有吸引力。隨著對更快、更全面和更少侵入性測試的需求不斷增加，多重技術在集中式實驗室和分散式照護端 (POC) 環境中變得越來越重要。

與傳統的單一分析物測試相比，多重分析可以提高診斷率並支持同時探討多種疾病原因的綜合測試方法。例如，呼吸道多重檢測面板可以同時檢測流感、SARS-CoV-2、RSV 和其他病原體，從而實現即時治療決策。這在流行病期間和免疫力缺乏的患者群體中尤其有用。隨著醫療保健系統向精準醫療和基於價值的護理模式發展，多重診斷提供了提供更豐富數據、降低每次測試成本和加快臨床決策週期的手段。

技術進步如何提升多重化能力和臨床效用？

微流體、生物感測器小型化、實驗室晶片平台和數位檢測技術的創新正在徹底改變連接複用診斷的性能和可訪問性。 Luminex以微珠為基礎的系統、PCR 微陣列、次世代定序(NGS) 和電化學生物感測器可實現具有高靈敏度、特異性和高通量的多重檢測。這些平台現在可以整合到桌上型分析儀、POC 墨盒或穿戴式裝置中，從而擴大其在傳統實驗室環境之外的用途。

多重技術（例如條碼探針面板和連接複用 ELISA 格式）正在擴大可在單次測試中檢測到的目標數量。基於 CRISPR 的診斷和等溫擴增方法正在實現低成本、可現場部署的連接複用平台。同時，人工智慧演算法和雲端基礎的分析正在整合到診斷工作流程中，以解釋複雜的多重數據並支援可操作的見解。自動化、小型化和智慧連接正在推動向可攜式、方便用戶使用的多重測試系統的轉變，適用於診所、緊急環境甚至家庭診斷。

哪些疾病領域和醫療保健模式正在推動多重診斷的需求？

感染疾病仍然是一個主要的應用領域，多重面板被廣泛用於識別與呼吸道感染疾病、性行為感染感染 (STI)、胃腸道疾病和敗血症相關的病原體。腫瘤學是一個新興的焦點，多重檢測用於突變分析、伴隨診斷和液態切片應用，這些應用需要同時檢測多種基因變異和/或生物標記。自體免疫和過敏診斷也受益於測量多種抗體和細胞激素譜的多重免疫測量。

由於需要整合工作流程和加快診斷速度，醫院、臨床實驗室、參考文獻實驗室和緊急護理中心是多重診斷的主要機構使用者。此外，透過快速門診、遠端醫療網路和行動醫療單位進行的分散式檢查的興起，正在推動對只需最低限度的技術培訓即可操作的緊湊型連接複用系統的需求。在基礎設施受限的情況下，中低收入國家正在探索綜合多重平台作為擴大診斷覆蓋率的一種經濟有效的方式。

什麼將推動多重診斷市場的長期成長和創新？

由於疾病日益複雜以及公共衛生監測的需要，全球對快速、高通量和全面的診斷解決方案的需求推動了多重診斷市場的成長。疫情防治、抗菌藥物管理和個人化腫瘤學正在共同加速多重檢測的採用。對綜合測試面板的監管支援和先進診斷工具的保險報銷也增加了市場的可行性。

開發人員正在投資擴展面板內容、提高檢體處理的自動化程度以及開發模組化平台以適應機構工作流程。診斷公司、生物技術公司和醫療保健提供者之間的策略夥伴關係正在推動綜合診斷和治療平台的聯合發展。此外，即時疾病監測、遠端攜帶式連接複用設備以及與數位健康的整合正在擴大這些技術的臨床效用。

隨著醫療保健越來越以數據主導並以患者為中心，多重診斷對於實現早期檢測、個人化治療和全系統效率至關重要，從而決定全球醫療保健生態系統診斷的未來。

部分

產品類型（儀器及配件、套件及試劑）；應用（感染疾病、腫瘤學、自體免疫疾病、心臟病學、過敏、其他應用）；最終用戶（醫院、診斷中心、其他最終用戶）

受訪公司範例（43家值得關注的公司）

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• BioFire Diagnostics
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Co-Diagnostics, Inc.
• DiaSorin SpA
• Exact Sciences Corporation
• Hologic, Inc.
• Illumina, Inc.
• Luminex Corporation
• NanoString Technologies, Inc.
• QIAGEN NV
• QuidelOrtho Corporation
• Randox Laboratories
• Roche Diagnostics
• Seegene Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口（成品和OEM）預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、降低盈利、重組供應鏈等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家（14,949）、智庫（62）和貿易及產業協會（171）的專家意見，以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計，這種動盪將在未來幾個月內平息，新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月：談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響，並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家，他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Multiplexed Diagnostics Market to Reach US$28.6 Billion by 2030

The global market for Multiplexed Diagnostics estimated at US$13.6 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Instruments & Accessories, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$15.4 Billion by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 16.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 17.3% CAGR

The Multiplexed Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.8% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR.

Global Multiplexed Diagnostics Market - Key Trends & Drivers Summarized

Why Is Multiplexed Diagnostics Gaining Prominence in Clinical Laboratories and Point-of-Care Testing?

Multiplexed diagnostics refers to analytical platforms capable of simultaneously detecting multiple analytes-such as proteins, nucleic acids, or pathogens-from a single biological sample. This approach significantly improves diagnostic efficiency, reduces turnaround time, and conserves sample volume, making it increasingly attractive for use in infectious disease testing, oncology, autoimmune disorder screening, and pharmacogenomics. With rising demand for faster, more comprehensive, and minimally invasive testing, multiplexing technologies are becoming central to both centralized laboratories and decentralized point-of-care (POC) settings.

Compared to traditional single-analyte tests, multiplex assays enhance diagnostic yield and support syndromic testing approaches where multiple causes of a condition are investigated in parallel. For example, respiratory multiplex panels can concurrently detect influenza, SARS-CoV-2, RSV, and other pathogens-guiding treatment decisions in real time. This is particularly valuable during epidemics or in immunocompromised patient populations. As healthcare systems transition toward precision medicine and value-based care models, multiplexed diagnostics provide a means to deliver richer data at lower per-test costs and faster clinical decision cycles.

How Are Technological Advancements Enhancing Multiplexing Capabilities and Clinical Utility?

Innovations in microfluidics, biosensor miniaturization, lab-on-chip platforms, and digital detection technologies are revolutionizing the performance and accessibility of multiplexed diagnostics. Luminex bead-based systems, PCR microarrays, next-generation sequencing (NGS), and electrochemical biosensors are enabling multiplex assays with high sensitivity, specificity, and throughput. These platforms can now be integrated into benchtop analyzers, POC cartridges, or wearable devices-extending their use beyond traditional laboratory environments.

Digital multiplexing techniques, such as barcoded probe panels and multiplexed ELISA formats, are expanding the number of targets that can be detected in a single run. CRISPR-based diagnostics and isothermal amplification methods are enabling low-cost, field-deployable multiplex platforms. Simultaneously, AI algorithms and cloud-based analytics are being integrated into diagnostic workflows to interpret complex multiplex data and support actionable insights. Automation, miniaturization, and smart connectivity are driving a shift toward portable, user-friendly multiplex testing systems suitable for clinics, emergency settings, and even home diagnostics.

Which Disease Areas and Healthcare Models Are Driving Demand for Multiplexed Diagnostics?

Infectious diseases remain the dominant application area, with multiplex panels used extensively for respiratory infections, sexually transmitted infections (STIs), gastrointestinal diseases, and sepsis-related pathogen identification. Oncology is an emerging focus, where multiplexed assays are used for mutation profiling, companion diagnostics, and liquid biopsy applications that require the simultaneous detection of multiple gene alterations or biomarkers. Autoimmune and allergy diagnostics are also benefiting from multiplexed immunoassays that measure multiple antibody or cytokine profiles.

Hospitals, clinical laboratories, reference labs, and urgent care centers are the key institutional users of multiplex diagnostics, driven by the need for workflow consolidation and faster diagnostic turnaround. Additionally, the rise of decentralized testing through retail health clinics, telemedicine networks, and mobile health units is creating demand for compact multiplex systems that can be operated with minimal technical training. Low- and middle-income countries are exploring syndromic multiplex platforms as a cost-effective way to expand diagnostic reach amid infrastructure constraints.

What Is Driving Long-Term Growth and Innovation in the Multiplexed Diagnostics Market?

The growth in the multiplexed diagnostics market is driven by the global demand for rapid, high-throughput, and comprehensive diagnostic solutions amid increasing disease complexity and public health surveillance needs. Outbreak preparedness, antimicrobial stewardship, and oncology personalization are aligning to accelerate the adoption of multiplex assays. Regulatory support for syndromic testing panels and reimbursement coverage for advanced diagnostic tools are also reinforcing market viability.

Manufacturers are investing in expanding panel content, improving sample processing automation, and developing modular platforms that can be tailored to institutional workflows. Strategic partnerships between diagnostic firms, biotech companies, and healthcare providers are driving co-development of integrated diagnostic-treatment platforms. Additionally, real-time disease monitoring, portable multiplex devices for remote settings, and digital health integration are extending the clinical utility of these technologies.

As healthcare delivery becomes increasingly data-driven and patient-centric, multiplexed diagnostics will serve as an essential enabler of early detection, personalized therapy, and system-wide efficiency-defining the future of diagnostics across global healthcare ecosystems.

SCOPE OF STUDY:

The report analyzes the Multiplexed Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments & Accessories, Kits & Reagents); Application (Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, Other Applications); End-User (Hospitals, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• BioFire Diagnostics
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Co-Diagnostics, Inc.
• DiaSorin S.p.A.
• Exact Sciences Corporation
• Hologic, Inc.
• Illumina, Inc.
• Luminex Corporation
• NanoString Technologies, Inc.
• QIAGEN N.V.
• QuidelOrtho Corporation
• Randox Laboratories
• Roche Diagnostics
• Seegene Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Multiplexed Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for High-Throughput Testing in Infectious Disease Panels Drives Adoption of Multiplexed Diagnostics
  • Expansion of Syndromic Testing Platforms Throws the Spotlight on Multi-Analyte Diagnostic Capabilities
  • Growth in Point-of-Care and Near-Patient Testing Fuels Use of Compact Multiplex Systems
  • Advancements in Microfluidics and Lab-on-Chip Technologies Propel Miniaturization and Portability
  • Increased Integration of AI and Data Analytics Enhances Interpretation of Complex Diagnostic Profiles
  • Surge in Oncology Biomarker Panels Spurs Innovation in Multi-Gene Expression Assays
  • Widespread Adoption in Respiratory Virus Detection Strengthens Market for Flu-COVID-RSV Panels
  • Regulatory Support for Panel-Based Diagnostics Accelerates Approvals in Infectious Disease Management
  • Focus on Personalized Medicine Drives Development of Targeted Multiplex Companion Diagnostics
  • Use of Multiplex PCR and Next-Generation Sequencing Expands Platform Versatility Across Indications
  • Demand for Cost-Effective Testing in Resource-Limited Settings Spurs Adoption of Multiplex Formats
  • Growth in Antibiotic Stewardship Programs Strengthens Relevance of Rapid Pathogen Identification Panels
  • Increased Use in Transplant, Sepsis, and Autoimmune Disease Diagnostics Broadens Clinical Utility
  • Collaborations Between Diagnostic Firms and Pharma Companies Enhance Drug-Response Testing Capabilities
  • Decentralization of Diagnostic Workflows Supports Integration in Ambulatory and Rural Healthcare Settings
  • Development of Multiplex Immunoassays and Serological Panels Expands Role in Surveillance Programs
  • OEM Investment in Automation and Workflow Integration Improves Lab Efficiency and Throughput
  • Focus on Panel Flexibility and Modular Testing Drives Customization for Niche Clinical Needs
  • Emergence of Home-Based and Self-Collection Multiplex Kits Expands Consumer Access and Monitoring
  • Increased Pandemic Preparedness Investments Sustain Demand for Scalable, Rapid Multi-Pathogen Detection
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Multiplexed Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiac Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Allergies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION